Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
Sanjay Singh Institute of Life Sciences, School of Science and Technology, Ahmedabad University, Ahmedabad, Gujarat, India Abstract: Therapeutic agents aimed at inhibiting a single molecular target have not been successful in cancer therapy, but rather they impart resistance. However, multi-target...
Enregistré dans:
Auteur principal: | Singh S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0fddc80cf1e046f99472a75fe1b0011d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
par: Ju RJ, et autres
Publié: (2016) -
Preclinical toxicological study of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in synergic ratio
par: Marjorie Coimbra Roque, et autres
Publié: (2021) -
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
par: Wi TI, et autres
Publié: (2020) -
Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
par: Franco YL, et autres
Publié: (2018) -
Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy
par: Roa,Ignacio, et autres
Publié: (2017)